Cara Therapeutics Inc. (CARA) Fundamentals

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
SHARE INFORMATION
Market Cap$ 618,385,397
Shares Outstanding53,725,925
Float37,934,812
Percent Float70.61%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 23,028,000
Latest Fiscal EPS$ -1.74
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions403
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months3,689,496
Institutional Holdings Percent94.8%
Institutional Sold Previous 3 Months6,846,577
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months163,737
Insider Holdings Percent3.9
Insider Sold Previous 3 Months10,800
Insider Shares Owned2,090,693
TRADING INFO
52 Week High$ 18.93
52 Week Low$ 7.40
52 Week High Change$ -13.65
21 Day Moving Average$ 9.9795
21 Day Extended Moving Average$ 10.323
50 Day Moving Average$ 9.3376
50 Day Extended Moving Average$ 9.7969
200 Day Moving Average$ 11.2679
200 Day Extended Moving Average$ 11.0825
10 Day Average Volume682,194
20 Day Average Volume559,089
30 Day Average Volume501,361
50 Day Average Volume497,492
Alpha-0.005182
Beta1.0118
Standard Deviation0.154471
R20.107336
7 Day Price Change$ 0.24
7 Day Percent Change2.13%
21 Day Price Change$ 1.80
21 Day Percent Change18.54%
30 Day Price Change$ 2.06
30 Day Percent Change21.8%
Month to Date Price Change$ 2.77
Month to Date Percent Change31.69%
Quarter to Date Price Change$ 2.38
Quarter to Date Percent Change26.07%
180 Day Price Change$ 1.11
180 Day Percent Change10.67%
200 Day Price Change$ -0.26
200 Day Percent Change-2.21%
Year to Date Price Change$ -0.67
Year to Date Percent Change-5.5%

Cara Therapeutics Inc. (CARA) Key Ratios

PROFITABILITY
EBIT Margin-137.1%
EBITDA Margin-136.6%
Pre-Tax Profit Margin-2,310.9%
Profit Margin Count17.76%
Gross Margin95.7%
Profit Margin TOT17.76%
INCOME STATEMENTS
Revenue$ 48,886,000
Revenue Per Share$ 0.9099
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.00
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio8.30
Leverage Ratio1.10
Quick Ratio7.90
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-9.10
Enterprise Value$ 470,138,507
Price to Sales12.6495
Price to Free Cash-13.60
PE High Last 5 Years164.70
Price To Book3.00
Price To Cash Flow25.00
PE Low Last 5 Years-6.10
Price to Tangible Book3.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover5.50
Invoice Turnover1.20
Assets Turnover0.10
Return Assets-29.62
Return on Equity-32.53
Return on Capital-31.96

Cara Therapeutics Inc. (CARA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOChristopher Posner
Emplyoees84
Last AuditUQ
CIK0001346830
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address107 Elm Street
9th Floor, 4 Stamford Plaza
Stamford, CT 6902
Websitehttps://www.caratherapeutics.com
Facsimile-
Telephone+1 203 406-3700
Email-


Your Recent History
NASDAQ
CARA
Cara Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.